Facebook
Twitter
LinkedIn
ForwardOnco-Nephrology Symposium 2025 - Livestream (virtual)
Overview
Course Director - Nelson Leung, M.D.
Co-Course Directors - Leticia Rolon, M.D., and Sandra Herrmann, M.D.
September 11 - 12, 2025 - Internet Live Activity - Rochester, Minnesota
Broadcast in Central Time
The purpose of the symposium is to introduce the latest updates and advances in the field of onco-nephrology with the intent of boosting knowledge and confidence in the provider that cares for patients with cancer related kidney disease. The best practices and management of cancer related kidney diseases are presented by national and international experts. Topics include, overcoming nephrotoxicity of chemotherapeutic agents, principles of drug dosing in patients with chronic kidney disease, patients with dialysis dependent end stage renal disease, and much more. The interactive format encourages an environment where participants can exchange ideas with the experts.
Call for Abstracts
As part of the Onco-Nephrology Symposium 2025, all participants involved in the area of onco-nephrology are invited to submit an abstract for a poster or oral presentation. Any projects that pertain to the training and practice of onco-nephrology or a focus on onco-nephrology disorders are welcome. They may include guidelines, randomized trials, outcome studies, practice innovations, case studies or descriptive analyses. Abstracts should be 300 words or less and may include one figure or table.
Abstract Eligibility: Original abstracts that either have or have not been presented at other meetings will be considered. Previously published abstracts should be sufficiently modified.
Submission Criteria:
- Create a profile if you have not done so already, then log into your account
- Complete and submit abstract form no later than May 10, 2025
- Abstracts are limited to 300 words
- Complete the form
Notification of Results: All primary authors will be notified by June 10, 2025 if their submission has been selected for presentation. Details regarding presentation will follow.
Presentation of Abstracts: Abstracts chosen for presentation will be uploaded to the conference website and presented during the live and livestream course.
Click here to Submit Abstract. E-mail sorensen.jessica@mayo.edu with questions.
Target Audience
This symposium is intended for physicians, advanced practice providers, nurses, medical students and other healthcare professionals in nephrology, hematology, oncology, hospital medicine, and internal medicine.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Describe how to manage nephrotoxicity caused by newly developed anticancer treatments.
- Manage kidney transplant complications in patients with malignancies.
- Recognize the risks of immunotherapy-related complications in kidney transplant recipients.
- Implement preventive measures for AKI in patients receiving conventional anticancer treatments.
- Evaluate glomerular filtration rate in cancer patients to determine appropriate anticancer treatment dosages.
- Identify paraneoplastic glomerular lesions.
- Manage kidney complications associated with dysproteinemias and stem cell transplants.
Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge or performance of any care or procedure(s) which may be discussed or taught in this course.
Program
Location
Broadcast in Central Time
Lodging arrangements are the sole responsibility of the individual registrant. Mayo Clinic School of Continuous Professional Development is not responsible for expenses incurred by an individual who is not confirmed and for whom space is not available at the meeting. Costs incurred by the registrant such as airline or hotel fees or penalties are the responsibility of the registrant.
Accreditation
Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Statement(s):
AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 14.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Healthcare Professionals:
A record of attendance will be provided to all registrants for requesting credits in accordance with state nursing boards, specialty societies or other professional associations.
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.
Available Credit
- 14.00 AMA PRA Category 1 Credit™
- 14.00 Attendance
Register
Price
Broadcast in Central Time
To claim credit for livestream participation in this course, learners must view the content during the hours posted for the live activity. This course is not approved for on-demand delivery.
Commitment to Equity, Diversity and Inclusion
Mayo Clinic School of Continuous Professional Development (MCSCPD) strives to foster a learning environment in which individual differences are valued, allowing all to achieve their fullest potential.
Cancellation and Refund Policy
View Cancellation and Refund Policy
All requests must be submitted in writing using the Contact Us Form.
Any use of this site constitutes your agreement to the Terms and Conditions of Registration.